J M Péron, H Dalton, J Izopet, N Kamar. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultAgedAntiviral Agents/therapeutic useEnd Stage Liver Disease/complicationsEnd Stage Liver Disease/drug therapyFemaleFranceGenotypeHepatitis E/complicationsHepatitis E/drug therapyHepatitis E/virologyHepatitis E virus/geneticsHumansMaleMiddle AgedRibavirin/therapeutic useUnited Kingdom
Substances: See more » Antiviral AgentsRibavirin
Year: 2011 PMID: 21281681 DOI: 10.1016/j.jhep.2011.01.009
Source DB: PubMed Journal: J Hepatol ISSN: 0168-8278 Impact factor: 25.083